Implementation of vascularized composite allografts in the United States: Recommendations from the ASTS VCA Ad Hoc committee and the executive committee

L. Cendales, D. Granger, M. Henry, J. Jones, Alan Norman Langnas, D. Levi, J. Magee, R. Merion, K. Olthoff, T. Pruett, J. Roberts, M. Abecassis

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Like all other areas of transplantation, vascularized composite allografts (VCA) has the capacity to transform the lives of patients, for the better or for the worse. It is this duality that mandates VCA be performed in centers prepared for the intricacies accompanying other transplant procedures. Similarly, the complexities of VCA require that the procedures be driven by surgeons and physicians with experience in the multidisciplinary management of immunocompromised postsurgical patients. Furthermore, the grafts should be considered as organs rather than tissues from a regulatory and a biological standpoint. The ASTS supports the field of VCA and has demonstrated its support and leadership by actively formulating a strategy for its systematic development. The goal of this document is to provide a framework for the prospective, thoughtful realization of VCA in the United States from the American Society of Transplant Surgeons (ASTS) perspective. The authors propose a structured framework for the development of a prospective, thoughtful realization of Vascularized Composite Allografts in the US from the ASTS perspective.

Original languageEnglish (US)
Pages (from-to)13-17
Number of pages5
JournalAmerican Journal of Transplantation
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Composite Tissue Allografts
Transplants
Immunocompromised Host
Surgeons
Transplantation
Physicians

Keywords

  • Composite allograft
  • composite tissue
  • composite tissue program
  • donor
  • oversight
  • reconstructive transplantation
  • regulations

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Implementation of vascularized composite allografts in the United States : Recommendations from the ASTS VCA Ad Hoc committee and the executive committee. / Cendales, L.; Granger, D.; Henry, M.; Jones, J.; Langnas, Alan Norman; Levi, D.; Magee, J.; Merion, R.; Olthoff, K.; Pruett, T.; Roberts, J.; Abecassis, M.

In: American Journal of Transplantation, Vol. 11, No. 1, 01.01.2011, p. 13-17.

Research output: Contribution to journalArticle

Cendales, L. ; Granger, D. ; Henry, M. ; Jones, J. ; Langnas, Alan Norman ; Levi, D. ; Magee, J. ; Merion, R. ; Olthoff, K. ; Pruett, T. ; Roberts, J. ; Abecassis, M. / Implementation of vascularized composite allografts in the United States : Recommendations from the ASTS VCA Ad Hoc committee and the executive committee. In: American Journal of Transplantation. 2011 ; Vol. 11, No. 1. pp. 13-17.
@article{179b755182e5412ba8119c2c1103892d,
title = "Implementation of vascularized composite allografts in the United States: Recommendations from the ASTS VCA Ad Hoc committee and the executive committee",
abstract = "Like all other areas of transplantation, vascularized composite allografts (VCA) has the capacity to transform the lives of patients, for the better or for the worse. It is this duality that mandates VCA be performed in centers prepared for the intricacies accompanying other transplant procedures. Similarly, the complexities of VCA require that the procedures be driven by surgeons and physicians with experience in the multidisciplinary management of immunocompromised postsurgical patients. Furthermore, the grafts should be considered as organs rather than tissues from a regulatory and a biological standpoint. The ASTS supports the field of VCA and has demonstrated its support and leadership by actively formulating a strategy for its systematic development. The goal of this document is to provide a framework for the prospective, thoughtful realization of VCA in the United States from the American Society of Transplant Surgeons (ASTS) perspective. The authors propose a structured framework for the development of a prospective, thoughtful realization of Vascularized Composite Allografts in the US from the ASTS perspective.",
keywords = "Composite allograft, composite tissue, composite tissue program, donor, oversight, reconstructive transplantation, regulations",
author = "L. Cendales and D. Granger and M. Henry and J. Jones and Langnas, {Alan Norman} and D. Levi and J. Magee and R. Merion and K. Olthoff and T. Pruett and J. Roberts and M. Abecassis",
year = "2011",
month = "1",
day = "1",
doi = "10.1111/j.1600-6143.2010.03374.x",
language = "English (US)",
volume = "11",
pages = "13--17",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Implementation of vascularized composite allografts in the United States

T2 - Recommendations from the ASTS VCA Ad Hoc committee and the executive committee

AU - Cendales, L.

AU - Granger, D.

AU - Henry, M.

AU - Jones, J.

AU - Langnas, Alan Norman

AU - Levi, D.

AU - Magee, J.

AU - Merion, R.

AU - Olthoff, K.

AU - Pruett, T.

AU - Roberts, J.

AU - Abecassis, M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Like all other areas of transplantation, vascularized composite allografts (VCA) has the capacity to transform the lives of patients, for the better or for the worse. It is this duality that mandates VCA be performed in centers prepared for the intricacies accompanying other transplant procedures. Similarly, the complexities of VCA require that the procedures be driven by surgeons and physicians with experience in the multidisciplinary management of immunocompromised postsurgical patients. Furthermore, the grafts should be considered as organs rather than tissues from a regulatory and a biological standpoint. The ASTS supports the field of VCA and has demonstrated its support and leadership by actively formulating a strategy for its systematic development. The goal of this document is to provide a framework for the prospective, thoughtful realization of VCA in the United States from the American Society of Transplant Surgeons (ASTS) perspective. The authors propose a structured framework for the development of a prospective, thoughtful realization of Vascularized Composite Allografts in the US from the ASTS perspective.

AB - Like all other areas of transplantation, vascularized composite allografts (VCA) has the capacity to transform the lives of patients, for the better or for the worse. It is this duality that mandates VCA be performed in centers prepared for the intricacies accompanying other transplant procedures. Similarly, the complexities of VCA require that the procedures be driven by surgeons and physicians with experience in the multidisciplinary management of immunocompromised postsurgical patients. Furthermore, the grafts should be considered as organs rather than tissues from a regulatory and a biological standpoint. The ASTS supports the field of VCA and has demonstrated its support and leadership by actively formulating a strategy for its systematic development. The goal of this document is to provide a framework for the prospective, thoughtful realization of VCA in the United States from the American Society of Transplant Surgeons (ASTS) perspective. The authors propose a structured framework for the development of a prospective, thoughtful realization of Vascularized Composite Allografts in the US from the ASTS perspective.

KW - Composite allograft

KW - composite tissue

KW - composite tissue program

KW - donor

KW - oversight

KW - reconstructive transplantation

KW - regulations

UR - http://www.scopus.com/inward/record.url?scp=78650892637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650892637&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2010.03374.x

DO - 10.1111/j.1600-6143.2010.03374.x

M3 - Article

C2 - 21199345

AN - SCOPUS:78650892637

VL - 11

SP - 13

EP - 17

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 1

ER -